A class of pharmacological or nutritional compounds designed to influence the structure of chromatin, the complex of DNA and proteins (histones) that forms chromosomes. These agents work to alter the accessibility of DNA to the transcriptional machinery, thereby regulating gene expression without changing the underlying DNA sequence. They are critical tools in epigenetic modulation.
Origin
The term arises from molecular biology and epigenetics, specifically the study of how DNA is packaged within the nucleus. Chromatin remodeling describes the dynamic process of altering this packaging, and the agents are the molecules used to clinically influence this process.
Mechanism
These agents function by targeting enzymes that add or remove chemical tags, such as acetyl or methyl groups, onto histones or DNA itself. For instance, histone deacetylase (HDAC) inhibitors promote a more open, transcriptionally active chromatin structure, potentially reactivating beneficial genes silenced by age. Conversely, DNA methyltransferase (DNMT) inhibitors can prevent inappropriate gene silencing. The mechanism is a precise biochemical manipulation of the cell’s genetic readout, impacting processes from cellular repair to hormonal responsiveness.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.